These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 6330507)

  • 1. Drugs versus biologicals. An immunologist's view of the therapeutic future.
    Nossal GJ
    Med J Aust; 1984 Jul; 141(2):100-4. PubMed ID: 6330507
    [No Abstract]   [Full Text] [Related]  

  • 2. The clearance of viruses and transmissible spongiform encephalopathy agents from biologicals.
    Farshid M; Taffs RE; Scott D; Asher DM; Brorson K
    Curr Opin Biotechnol; 2005 Oct; 16(5):561-7. PubMed ID: 16095899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Modern anti-cancer therapy: current state and future developments].
    Bokemeyer C; Hiddemann W
    Dtsch Med Wochenschr; 2014 Oct; 139(41):2067. PubMed ID: 25268204
    [No Abstract]   [Full Text] [Related]  

  • 4. Biotechnology: an overview of the tools, therapeutic agents, and applications to pharmacy practice.
    Piascik P
    Pharm Pract Manag Q; 1998 Jul; 18(2):1-12. PubMed ID: 10185234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Tomorrow's drugs].
    Legrain M
    Cah Sociol Demogr Med; 1983; 23(2):149-59. PubMed ID: 6883157
    [No Abstract]   [Full Text] [Related]  

  • 6. Biopharmaceuticals in China.
    Hu X; Ma Q; Zhang S
    Biotechnol J; 2006 Nov; 1(11):1215-24. PubMed ID: 17089435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent progress in biomolecular engineering.
    Ryu DD; Nam DH
    Biotechnol Prog; 2000; 16(1):2-16. PubMed ID: 10662483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The parasite immunologist's crystal ball.
    Riley E; Grencis R
    Parasite Immunol; 2006 Jun; 28(6):233-4. PubMed ID: 16704464
    [No Abstract]   [Full Text] [Related]  

  • 9. Application of cell engineering technology to the tumour immunotherapeutic drug: a review.
    Chen ZN; Xing JL; Bian HJ; Mi L; Jiang JL
    Cell Biol Int; 2001; 25(10):1013-5. PubMed ID: 11589619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic engineering of natural products in plants; tools of the trade and challenges for the future.
    Wu S; Chappell J
    Curr Opin Biotechnol; 2008 Apr; 19(2):145-52. PubMed ID: 18375112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biologicals: new horizons in pharmaceutical development.
    Oldham RK
    J Biol Response Mod; 1983; 2(3):199-206. PubMed ID: 6358418
    [No Abstract]   [Full Text] [Related]  

  • 12. Recombinant protein therapeutics--success rates, market trends and values to 2010.
    Pavlou AK; Reichert JM
    Nat Biotechnol; 2004 Dec; 22(12):1513-9. PubMed ID: 15583654
    [No Abstract]   [Full Text] [Related]  

  • 13. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biosimulation software is changing research.
    Ho RL; Bartsell LT
    Biotechnol Annu Rev; 2004; 10():297-302. PubMed ID: 15504712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Guidelines in respect of biotechnological products.
    Smith JW
    Arzneimittelforschung; 1985; 35(1):176-7. PubMed ID: 3857046
    [No Abstract]   [Full Text] [Related]  

  • 16. The quiet revolution.
    Nat Biotechnol; 2003 Jul; 21(7):715. PubMed ID: 12833072
    [No Abstract]   [Full Text] [Related]  

  • 17. Natural products as leads to potential drugs: an old process or the new hope for drug discovery?
    Newman DJ
    J Med Chem; 2008 May; 51(9):2589-99. PubMed ID: 18393402
    [No Abstract]   [Full Text] [Related]  

  • 18. Targeted intracellular delivery of therapeutics: an overview.
    Rawat A; Vaidya B; Khatri K; Goyal AK; Gupta PN; Mahor S; Paliwal R; Rai S; Vyas SP
    Pharmazie; 2007 Sep; 62(9):643-58. PubMed ID: 17944316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Biotechnological approaches to the development of therapeutic and diagnostic preparations of lipid nature].
    Shvetz VI; Krasnopol'skiĭ IuM; Kaplun AP; Stepanov AE
    Vopr Med Khim; 1997; 43(5):416-24. PubMed ID: 9446330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suggested standards for shipping thermolabile drugs & biologicals.
    Beretta JJ
    Am J Hosp Pharm; 1966 Jan; 23(1):27-31. PubMed ID: 5901351
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.